CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
DepressionEpilepsy, Temporal Lobe
Interventions
OTHER

Cognitive behavioral therapy

"The CBT group will receive 12 weekly 90-minute sessions. Each session will be given in group form by one certified CBT therapist and one neuropsychiatrist in training on group therapy.~The CBT structure include psychoeducation, addressing dysfunctional thoughts and maladaptive behaviors; problem solving techniques, assertiveness, coping strategies and depression relapse prevention"

DRUG

SSRI

"Patients will receive the treatment as usual with a SSRI: sertraline or citalopram. In patients already taking antidepressants for more than 8 weeks before enrollment but still experiencing depressive symptoms, treatment could be optimized either by augmenting the dose of his antidepressant or by changing to one of the SSRI mentioned."

Trial Locations (1)

14269

Instituto Nacional de Neurología y Neurocirugía MVS, México

All Listed Sponsors
lead

El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

OTHER

NCT02262156 - CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients | Biotech Hunter | Biotech Hunter